New Ray Medicine International Holding Ltd. (6108)
Market Closed
13 Aug, 08:00
HKEX HKEX Primary 0. 21
HKD +0.01
+2.381%
76.91M Market Cap
- P/E Ratio
- Div Yield
137,600 Volume
- Eps
0.21 HKD
Previous Close Want to track 6108 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
6108 closed yesterday higher at 0.21 HKD, an increase of 2.381% from Wednesday's close, completing a monthly increase of 4.3689% or 0.01 HKD. Over the past 12 months, 6108 stock lost -20.3704%.
6108 is not paying dividends to its shareholders.
New Ray Medicine International Holding Ltd. has completed 2 stock splits, with the recent split occurring on Jul 22, 2025.
The company's stock is traded on one exchange.
6108 Chart
New Ray Medicine International Holding Ltd. (6108) FAQ
What is the stock price today?
The current price is 0.21 HKD.
On which exchange is it traded?
New Ray Medicine International Holding Ltd. is listed on HKEX.
What is its stock symbol?
The ticker symbol is 6108.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 76.91M.
Has New Ray Medicine International Holding Ltd. ever had a stock split?
New Ray Medicine International Holding Ltd. had 2 splits and the recent split was on Jul 22, 2025.
New Ray Medicine International Holding Ltd. Profile
| Pharmaceuticals Industry | Healthcare Sector | Ms. Qiuqin Wang CEO | HKEX Exchange | - ISIN |
| China Country | 23 Employees | - Last Dividend | 15 Mar 2016 Last Split | - IPO Date |
Overview
New Ray Medicine International Holding Limited operates as an investment holding company primarily focused on the distribution and trading of injection drugs and pharmaceutical products within the People's Republic of China. Established in 2001 and headquartered in Hangzhou, the company plays a significant role in the Chinese pharmaceutical market by offering a wide range of drugs for various medical conditions, along with marketing and promotion services for these drugs.
Products and Services
The company's product portfolio includes a comprehensive array of pharmaceutical products, covering a broad spectrum of health conditions:
- Injections, Capsules, Tablets, and Other Drugs: These are designed for the treatment of diseases such as muscular dystrophy, cardiomyopathy, and various heart conditions including acute and chronic myocardial infarction, angina pectoris. They also cater to nutritional needs through parenteral nutrition and treat liver diseases including hepatitis, HBe antigen-positive conditions, decompensated liver cirrhosis, and severe hepatitis, as well as tumor relating hepatitis B and chronic hepatitis C.
- Antimicrobial and Antibiotic Treatments: The company provides solutions for respiratory tract infections, urinary tract infections, genitourinary system infections, intra-abdominal infections, bone and joint infections, septicemia, hypermetabolism, pneumonia, skin and soft tissue infections, pelvic inflammatory diseases, diarrhea, and other conditions related to the digestive system. These treatments are crucial for combating biliary tract infections and other infections.
- Marketing and Promotion Services: Besides its product offerings, New Ray Medicine International Holding Limited assists in the marketing and promotion of drugs. This service ensures that healthcare providers are informed about the latest pharmaceuticals available, enhancing the accessibility and effective utilization of these medical supplies.
Contact Information
Address: Dikai International Center
Phone: -
Website: https://www.newraymedicine.com
